Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy
Public ClinicalTrials.gov record NCT05429372. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2, MULTICENTER, SINGLE-ARM STUDY TO EVALUATE THE SAFETY AND DYSTROPHIN EXPRESSION AFTER FORDADISTROGENE MOVAPARVOVEC (PF-06939926) ADMINISTRATION IN MALE PARTICIPANTS WITH EARLY STAGE DUCHENNE MUSCULAR DYSTROPHY
Study identification
- NCT ID
- NCT05429372
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 10 participants
Conditions and interventions
Conditions
Interventions
- PF-06939926 Genetic
Genetic
Eligibility (public fields only)
- Age range
- 2 Years to 3 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 7, 2022
- Primary completion
- Oct 2, 2025
- Completion
- Oct 2, 2025
- Last update posted
- Oct 20, 2025
2022 – 2025
United States locations
- U.S. sites
- 10
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UF Health Shands Hospital | Gainesville | Florida | 32610 | — |
| University of Florida | Gainesville | Florida | 32610 | — |
| The Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| The Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19146 | — |
| CTSI Clinical Research Center | Salt Lake City | Utah | 84108 | — |
| University of Utah Imaging and Neurosciences Center | Salt Lake City | Utah | 84108 | — |
| University of Utah Hospital & Clinics Investigational Drug Services | Salt Lake City | Utah | 84112 | — |
| Primary Children's Hospital | Salt Lake City | Utah | 84113 | — |
| University of Utah Clinical Neurosciences Center | Salt Lake City | Utah | 84132 | — |
| University of Utah Hospital | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05429372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2025 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05429372 live on ClinicalTrials.gov.